Polaryx Therapeutics Inc. Common Stock

PLYX | NASDAQ

$1.76

+$0.01 (+0.57%)

Nov 2, 2026, 2:47 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023
Cash & Equivalents	5.14M	4.62M	2K
Short-Term Investments	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a
Receivables	n/a	n/a	n/a
Inventory	n/a	n/a	n/a
Other Current Assets	27K	n/a	n/a
Total Current Assets	5.17M	5M	2.32M
Property-Plant & Equipment	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a
Total Long-Term Assets	250K	n/a	n/a
Total Assets	5.42M	5M	2.32M
Account Payables	470K	72K	473K
Deferred Revenue	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	128K
Other Current Liabilities	21K	1K	1K
Total Current Liabilities	605K	289K	1.04M
Long-Term Debt	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a
Total Long-Term Liabilities	250K	n/a	n/a
Total Liabilities	855K	289K	1.04M
Total Debt	n/a	n/a	128K
Book Value	4.57M	4.71M	1.28M
Book Value Per Share	0.10	0.02	0.01
Common Stock	5K	16K	4K
Retained Earnings	-99.64M	-90.65M	-60.29M
Comprehensive Income	n/a	n/a	n/a
Shareholders Equity	4.57M	4.71M	1.28M
Total Investments	n/a	n/a	n/a